Keystone Resort Floorplan

Registered Attendees


Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:

  • Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)

    NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.

  • Full participant list, including joint meeting participants
  • Printable Invoices and Invitation Letters
  • Scholarship Information
  • Lodging Information

Login to My Account page

This meeting took place in 2017



For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

Microbiome in Health and Disease (J8)


Organizer(s) Julie A. Segre, Ramnik Xavier and William Michael Dunne
February 5—9, 2017
Keystone Resort • Keystone, Colorado USA
Discounted Abstract Deadline: Oct 6, 2016
Abstract Deadline: Nov 3, 2016
Scholarship Deadline: Oct 6, 2016
Discounted Registration Deadline: Dec 7, 2016

Sponsored by Intercept Pharmaceuticals, Inc., Merck & Co., Inc. and Novartis Institutes for BioMedical Research. Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation.


Summary of Meeting:
This Keystone Symposia meeting brings together experts in clinical medicine, clinical microbiology, microbial genomics, and bacterial genetics to explore how both strain variation and underlying microbial community determine health and disease. Genomic advances provide higher-level resolution to both pathogen and host genetic determinants. This meeting aims to explore how monitoring and potentially altering the microbial community may modulate and predict disease risk.

View Scholarships/Awards
No registration fees are used to fund entertainment or alcohol at this conference

Conference Program    Print  |   View meeting in 12 hr (am/pm) time


The meeting will begin on Sunday, February 5 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Thursday, February 9 with a closing plenary session from 17:00 to 19:15, followed by a social hour and entertainment. We recommend return travel on Friday, February 10 in order to fully experience the meeting.

SUNDAY, FEBRUARY 5

16:00—20:00
Arrival and Registration

Longs Peak Foyer
18:00—20:00
Welcome Mixer
No registration fees are used to fund alcohol served at this function.

Longs Peak Foyer

MONDAY, FEBRUARY 6

07:00—08:00
Breakfast

Colorado Rockies Ballroom
08:00—09:00
Welcome and Keynote Address
Meeting has ended...abstracts no longer viewable online.

Grays/Longs Peak
* Julie A. Segre, NHGRI, National Institutes of Health, USA

Sarkis K. Mazmanian, California Institute of Technology, USA
The Gut-Microbiome-Brain Connection in Neurological Diseases

08:00—09:00
Welcome and Keynote Address
Meeting has ended...abstracts no longer viewable online.

Quandary Peak
* Fiona M. Powrie, University of Oxford, UK

Lisa M. Coussens, Oregon Health & Science University, USA
Manipulating the Tumor Microenvironment in Cancer Therapy

09:00—11:15
Monitoring Microbiome to Predict Disease Risk
Meeting has ended...abstracts no longer viewable online.

Grays/Longs Peak
* William Michael Dunne, bioMérieux, Inc., USA

Hera Vlamakis, Broad Institute, USA
IBD, Crohn’s Microbiome

Coffee Break

Dan R. Littman, HHMI/New York University School of Medicine, USA
Regulation of T Cell Responses by Microbiota

Curtis C. Harris, NCI, National Institutes of Health, USA
Microbiome-TP53 Gene Interaction in Human Lung Cancer

09:00—11:15
Inflammation-Driven Cancer
Meeting has ended...abstracts no longer viewable online.

Quandary Peak
* Michael Karin, University of California, San Diego, USA

Fiona M. Powrie, University of Oxford, UK
Inflammation-Driven Cancer: Host and Microbial Pathways

Coffee Break

Mathias Florian Heikenwälder, German Cancer Research Center, DKFZ, Germany
On the Role of Immune Cells in NASH and NASH to HCC Transition

Arthur Kaser, University of Cambridge, UK
ER Stress and Colorectal Cancer

Jeonghyun Ahn, University of Miami, USA
Short Talk: The Role of STING in Suppressing Inflammation-Driven Intestinal Tumorigenesis

11:15—12:30
NIH Institutes’ Interests in Microbiome Research

Grays/Longs Peak
* Robert W. Karp, National Institutes of Health, USA

Ryan Ranallo, NIAID, National Institutes of Health, USA

Phil J. Daschner, NCI, National Institutes of Health, USA

Elisabet Caler, NHLBI, National Institutes of Health, USA

Ricardo Cibotti, NIAMS, National Institutes of Health, USA

Francesca Macchiarini, NIA, National Institutes of Health, USA

11:15—13:00
Poster Setup

Colorado Rockies Ballroom
12:30—17:00
On Own for Lunch

13:00—22:00
Poster Viewing

Colorado Rockies Ballroom
14:30—16:30
Workshop 1: Microbiome in Health and Disease

Grays/Longs Peak
* Ami S. Bhatt, Stanford University, USA

Michael C. Abt, Sloan Kettering Institute, USA
Host Immune Response Supports Fecal Microbiota Transplant-Mediated Clearance of Clostridium Difficile Infection

Dingding An, Harvard Medical School, USA
Microbial Sphingolipids Modulate Host Epithelium Homeostasis and Disease

Naama Geva-Zatorsky, Harvard Medical School, USA
Gut Microbiota-Host Interactions and their Immune Modulations

Yun-Gi Kim, Keio University, Japan
Neonatal Acquisition of Clostridia Species Controls Colonization Resistance Against Bacterial Pathogens

Monica Viladomiu, Weill Cornell Medicine, USA
Functional Characterization of IgA-Targeted E. coli in Crohn's Disease-Associated Spondyloarthritis Links Mucosal Immunity with Systemic Inflammation

Xochitl Morgan, University of Otago, New Zealand
Gut Microbiota Acquisition in New Zealand Children in Relation to Early Life Exposures Including Probiotics: A Longitudinal Analysis

14:30—16:30
Workshop 1: Inflammation-Driven Cancer

Quandary Peak
* Mathias Florian Heikenwälder, German Cancer Research Center, DKFZ, Germany

* Hua E. Yu, Beckman Research Institute, City of Hope, USA

Ryan Kolb, University of Iowa, USA
IL-1beta Promotes Obesity-driven Breast Cancer Progression through the Upregulation of ANGPTL4 in Adipocytes

Sarah McCuaig, University of Oxford, UK
Cytokine-Oncogene Synergies in Colorectal Cancer

Seyed Javad Moghaddam, University of Texas MD Anderson Cancer Center, USA
Muc5ac Plays an Essential Role in Promotion of K-ras Mutant Lung Cancer by Inflammation

Karen Pickering, Beatson Institute, UK
Guanine Nucleotide Exchange Factor Vav1 Promotes Survival in Colorectal Cancer through T-Cell Activation

Na-Young Song, NCI, National Institutes of Health, USA
Determining the Signaling Pathway of Epithelial-IKKalpha-Deletion-Mediated Symbiotic Bacterial and Fungal Infection in Carcinogenesis

Chunfeng Qu, Cancer Institute/Hospital, Chinese Academy of Medical Sciences, China
Liver Inflammatory Macrophages in Response to Hepatitis B Virus (HBV) Proteins Promote Hepatocellular Carcinoma by Enhancing Angiogenesis through IL23/IL23R Interaction

Martina Seiffert, German Cancer Research Center, Germany
Tumor Exosome-Derived Y RNA Activates TLR7/8 Signaling in Monocytes and Contributes to Cancer Inflammation and Immune Escape

16:30—17:00
Coffee Available

Longs Peak Foyer
17:00—19:15
Microbiome and Cancer (Joint)
Meeting has ended...abstracts no longer viewable online.

Longs/Grays Peak
* Arthur Kaser, University of Cambridge, UK

Laurence Zitvogel, Institut Gustave Roussy, France
Microbe-Driven Anti-Tumor Immunity

Giorgio Trinchieri, NCI, National Institutes of Health, USA
Role of the Microbiota in Inflammation, Carcinogenesis and Cancer Therapy

Curtis Huttenhower, Harvard School of Public Health, USA
Functional Analysis of Strains in the Human Gut Metatranscriptome

Cynthia L. Sears, Johns Hopkins University School of Medicine, USA
The carcinogenic potential of bacterial biofilms

19:15—20:15
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Colorado Rockies Ballroom
19:30—22:00
Poster Session 1

Colorado Rockies Ballroom

TUESDAY, FEBRUARY 7

07:00—08:00
Breakfast

Colorado Rockies Ballroom
08:00—11:00
Complex Microbiome Analyses
Meeting has ended...abstracts no longer viewable online.

Grays/Longs Peak
* Julie A. Segre, NHGRI, National Institutes of Health, USA

Rob Knight, University of California, San Diego, USA
Human Microbiome and Metabolome Dynamics

Gautam Dantas, Washington University School of Medicine, USA
Networks of Exchanging Antibiotic Resistance Between Commensal, Environmental, and Pathogenic Bacteria

Coffee Break

Michael A. Fischbach, University of California, San Francisco, USA
Small Molecules from the Human Microbiota

Katherine S. Pollard, University of California, San Francisco, USA
Decoding Cryptic Variation in the Human Microbiome

Kelly Wen Li Chen, Massachusetts Institute of Technology, USA
Short Talk: Integrated Gut/Liver Microphysiological System Elucidates Cytokine/Chemokine Inter-Tissue Crosstalk under Endotoxin-Induced Stress

08:00—11:15
Inflammation and Cancer Stem Cells
Meeting has ended...abstracts no longer viewable online.

Quandary Peak
* Owen J. Sansom, Beatson Institute of Cancer Research, UK

Matthias Ernst, Olivia Newton-John Cancer Research Institute, Australia
Excessive HCK Kinase Activity in the Tumor Stroma Polarizes Macrophages and Promotes Solid Malignancies

Simon J. Leedham, University of Oxford, UK
Morphogen Signaling in Intestinal Inflammation and Carcinogenesis

Coffee Break

Fiona M. Watt, King's College London School of Medicine, UK
Contribution of Different Epidermal Cell Populations to Inflammation-Associated Cancers

Judith A. Varner, University of California, San Diego, USA
Targeting Macrophage Signaling to Suppress Tumor Progression

Min-Kyung Choo, Massachusetts General Hospital/Harvard Medical School, USA
Short Talk: p38 MAPK Functions as a Tumor Suppressor in Skin Epithelial Cells, but as a Tumor Promoter in Myeloid Cells

Jelena Todoric, University of California, San Diego, USA
Short Talk: A Stress Activated p62-NRF2-MDM2 Axis Drives Pancreatic Tumorigenesis

11:00—17:00
On Own for Lunch

11:00—13:00
Poster Setup

Colorado Rockies Ballroom
13:00—22:00
Poster Viewing

Colorado Rockies Ballroom
14:30—16:30
Panel: The Integrative Human Microbiome Project (iHMP)
The Integrative Human Microbiome Project (iHMP) is the second phase of the National Institute of Health (NIH) Common Fund's Human Microbiome Project (HMP) program. The mission of the overall HMP is to generate resources to permit comprehensive characterization of the human microbiota to further our understanding of how the microbiome impacts human health and disease. In this phase of the program, the iHMP is creating integrated longitudinal datasets of biological properties from both the microbiome and host from three different cohort studies of microbiome-associated conditions using multiple "omics" technologies. Tools, datasets and other resources from the first phase of the project are available at the HMP DACC. The three iHMP projects have recently completed primary data generation and are entering an initial analysis phase, and this session will detail the data and resources made available to the research community by: 1) the Multi-Omic Microbiome Study: Pregnancy Initiative (MOMS-PI) at Virginia Commonwealth University, 2) the Inflammatory Bowel Disease Multi'omic Data (IBDMDB) resource from the Broad Institute and a nation-wide research tam, and 3) Integrated Personal 'Omics Profiling (IPOP) from Stanford University and the Jackson Laboratory for Genomic Medicine. For more information or to get involved with the iHMP, please see http://hmp2.org.

Grays/Longs Peak
* Curtis Huttenhower, Harvard School of Public Health, USA

Jennifer M. Fettweis, Virginia Commonwealth University, USA

George M. Weinstock, The Jackson Laboratory, USA

Anup Mahurkar, University of Maryland Baltimore, USA

14:30—16:30
Workshop 2: Inflammation and Immunity Crosstalk

Quandary Peak
* Giorgio Trinchieri, NCI, National Institutes of Health, USA

* Laurence Zitvogel, Institut Gustave Roussy, France

Giuseppe Di Caro, University of California, San Diego, USA
Immunoglobulin A Attenuates Colonic Tumorigenesis by Controlling Microbial Translocation and Tumor-Elicited Inflammation

Ankit Malik, St Jude Children's Research Hospital, USA
IL-33 Regulates the IgA-Microbiota Axis to Restrain IL-1alpha Dependent Colitis and Tumorigenesis

Andrea Ponzetta, Humanitas Clinical and Research Center, Italy
Neutrophils are Protective in Cancerogenesis by Altering Tumor Microenvironment and Controlling Intestinal Microbiota

Sabine Waeber, Université de Lausanne, Switzerland
Mesenchymal Stem Cells from Human Squamous Cell Lung Carcinoma Modulate Natural Killer (NK) Cell Phenotype and Function

Martina Molgora, Humanitas Research Hospital, Italy
Interleukin-1 Receptor 8 (IL-1R8) Plays a Crucial Role in Natural Killer Cell Differentiation and Function

Venuprasad K. Poojary, Baylor Institute for Immunology Research, USA
A Novel Role for Itch in Inhibition of IL-17-Mediated Colon Inflammation and Tumorigenesis by ROR-gammat Ubiquitination

Christoph Andreas Reichel, Walter Brendel Centre of Experimental Medicine, Germany
Complex Formation of uPA and PAI-1 Promotes Myeloid Leukocyte Trafficking

16:30—17:00
Coffee Available

Longs Peak Foyer
17:00—19:00
Human Microbiome Studies
Meeting has ended...abstracts no longer viewable online.

Grays/Longs Peak
* Robert E.W. Hancock, University of British Columbia, Canada

Andrew L. Goodman, Yale School of Medicine, USA
Cooperation and Competition in the Human Gut Microbiome

Julie A. Segre, NHGRI, National Institutes of Health, USA
Human Skin Microbiome: Topographic Functional Mapping of Healthy Volunteers and Patient Populations

Gary D. Wu, University of Pennsylvania School of Medicine, USA
Diet, the Gut Microbiome and Inflammatory Bowel Disease

Renuka Nayak, University of California, San Francisco, USA
Short Talk: Methotrexate Is an Antibacterial Drug Metabolized by Human Gut Bacteria

17:00—19:00
Tumor-Elicited Inflammation
Meeting has ended...abstracts no longer viewable online.

Quandary Peak
* Ming O. Li, Memorial Sloan Kettering Cancer Center, USA

Yinling Hu, National Cancer Institute at Frederick, USA
IKKalpha, Autoimmunity and Chronic Fungal Infection in Esophageal and Skin Carcinogenesis

Hua E. Yu, Beckman Research Institute, City of Hope, USA
Stat 3 in Cancer Inflammation and as a Target in Cancer

Owen J. Sansom, Beatson Institute of Cancer Research, UK
Targeting Myeloid Cells in Epithelial Cancers

Elena Tosti, Albert Einstein College of Medicine, USA
Short Talk: MMR and Tgfb Signaling Cooperate in Suppressing Inflammation-Associated Colorectal Tumorigenesis

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Colorado Rockies Ballroom
19:30—22:00
Poster Session 2

Colorado Rockies Ballroom

WEDNESDAY, FEBRUARY 8

07:00—08:00
Breakfast

Colorado Rockies Ballroom
08:00—11:00
Genetic Diversity and Communication
Meeting has ended...abstracts no longer viewable online.

Grays/Longs Peak
* Thaddeus S. Stappenbeck, Washington University School of Medicine, USA

Karen Guillemin, University of Oregon, USA
Modulation of Host Innate Immune Responses by Individual Microbiota Members

Eran Segal, Weizmann Institute of Science, Israel
Personalized Nutrition using Gut Microbiome and Clinical Data

Coffee Break

Robert E.W. Hancock, University of British Columbia, Canada
Network Biology Approaches to Understanding Inflammation

James M. Musser, Methodist Hospital Research Institute, USA
Integrative Approach to Investigating Human Pathogen-Host Interactions: A Nightmare of Genomic Diversity?

Mahesh S. Desai, Luxembourg Institute of Health, Luxembourg
Short Talk: A Dietary Fiber-Deprived Gut Microbiota Degrades the Colonic Mucus Barrier and Enhances Pathogen Susceptibility

08:00—11:15
Inflammation and Immunity Crosstalk I
Meeting has ended...abstracts no longer viewable online.

Quandary Peak
* Shannon J. Turley, Genentech, Inc., USA

Michael Karin, University of California, San Diego, USA
Immune Crosstalk in Tumors

Alberto Mantovani, Humanitas University, Italy
Innate Immune Pathways and the Tumor Microenvironment

Coffee Break

Ming O. Li, Memorial Sloan Kettering Cancer Center, USA
Immunity and Tolerance in Cancer

Toby Lawrence, INSERM, France
Mechanisms of Tumour-Associated Macrophage (TAM) Polarisation

Sven Brandau, University Duisburg-Essen, Germany
Short Talk: Absence of Endogenous Toll-Like Receptor Sensing Unleashes Protective Anti-Tumor Immunity and Tumor Regression

George Plitas, Memorial Sloan Kettering Cancer Center, USA
Short Talk: CD177 Identifies a Novel Subset of Regulatory T Cells (Treg) Infiltrating Human Breast Cancer

11:00—17:00
On Own for Lunch

11:00—13:00
Poster Setup

Colorado Rockies Ballroom
13:00—22:00
Poster Viewing

Colorado Rockies Ballroom
16:30—17:00
Coffee Available

Longs Peak Foyer
17:00—19:00
Microbiome and Disease
Meeting has ended...abstracts no longer viewable online.

Grays/Longs Peak
* Timothy K. Lu, Massachusetts Institute of Technology, USA

Thaddeus S. Stappenbeck, Washington University School of Medicine, USA
Microbial Metabolites that Modify Intestinal Wound Repair

Kathryn E. Holt, University of Melbourne, Australia
Klebsiella Pneumoniae and the Microbiome

Ami S. Bhatt, Stanford University, USA
Metagenomics and the Microbiome in Stem Cell Transplantation

Lindsay R. Kalan, University of Pennsylvania, USA
Short Talk: Multi-Kingdom Microbial Communities of Chronic Non-Healing Wounds and their Association with Clinical Outcomes

17:00—19:00
Stromal Cells and the Tumor Microenvironment
Meeting has ended...abstracts no longer viewable online.

Quandary Peak
* Alberto Mantovani, Humanitas University, Italy

Shannon J. Turley, Genentech, Inc., USA
Leukocyte Function and Positioning in Diverse Stromal Niches

Daniel L. Worthley, SAHMRI, Adelaide, Australia
Intestinal Mesenchyme in the Normal and Neoplastic Colon

Raghu Kalluri, University of Texas MD Anderson Cancer Center, USA
The Functional Role of Inflammation and Fibrosis in Pancreatic Cancer

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Colorado Rockies Ballroom
19:30—22:00
Poster Session 3

Colorado Rockies Ballroom

THURSDAY, FEBRUARY 9

07:00—08:00
Breakfast

Colorado Rockies Ballroom
08:00—11:00
Molecular Discovery of Novel Antimicrobials
Meeting has ended...abstracts no longer viewable online.

Grays/Longs Peak
* Sean F. Brady, Rockefeller University, USA

Andreas Peschel, University of Tübingen, Germany
Staphylococcus Aureus in the Human Nose – A Facultative Pathogen's Interference with Microbiota

William Michael Dunne, bioMérieux, Inc., USA
Next-Generation Antimicrobial Susceptibility Testing

Coffee Break

Eric J. Alm, Massachusetts Institute of Technology, USA
FMT Complex Analyses

Silvio M. Vieira, Yale University, USA
Short Talk: A Gut Commensal Breaches Both Gut Lymphatic and Vascular Barriers to Drive Systemic Autoimmunity

Jonathan L. Linehan, NIAID, National Institutes of Health, USA
Short Talk: Cutaneous Commensal Bacteria Drive an Unconventional T Cell Response that Accelerates Wound Healing

08:00—11:00
Inflammation and Immunity Crosstalk II
Meeting has ended...abstracts no longer viewable online.

Quandary Peak
* Jane L. Grogan, Genentech, Inc., USA

Weiping Zou, University of Michigan, USA
Metabolic Control of Effector T Cells and Regulatory T Cells in Tumor

Thomas Gajewski, University of Chicago, USA
Host Factors Controlling Anti-Tumor Immunity: Unexpected Impact of the Commensal Microbiota

Coffee Break

E. John Wherry, University of Pennsylvania, USA
Molecular Basis of T Cell Exhaustion: Insights for Immunotherapy

Martin Oft, ARMO BioSciences, USA
PEGylated IL-10 Induces Th1 and Th2 Immunity, Proliferation of PD1+ Lag-3+ CD8+ T Cells and Multiclonal T Cell Expansion in Cancer Patients

Bronislaw Pytowski, Eli Lilly, USA
Short Talk: The Effect of VEGFR2 Inhibition on Tumor Blood Vessels and Immune Landscape

11:00—17:00
On Own for Lunch

14:30—16:30
Workshop 2: Metagenomic Analysis

Grays/Longs Peak
* Eric J. Alm, Massachusetts Institute of Technology, USA

Michael G. Constantinides, NIAID, National Institutes of Health, USA
Mucosal-Associated Invariant T Cells Respond to Cutaneous Microbiota

Collin Edington, Massachusetts Institute of Technology, USA
Development of Bioreactor Devices for Microbiome and Multi-Organ Interaction Studies

Sho Kitamoto, University of MIchigan Medical School, USA
Gut Inflammation-Driven Metabolic Reprograming Regulates the Competitive Fitness of Pathogenic E. coli

David T. Riglar, Harvard Medical School, USA
Gut Feelings: Engineering Synthetic Bacterial Circuits to Functionally Probe the Mammalian Gut Microbiome

Neil Surana, Harvard Medical School, USA
Discovery of Disease-Modulating Microbiota Using Microbial Pedigree Analysis

Ana Weil, Massachusetts General Hospital, USA
The Human Gut Microbiota Predicts Susceptibility to Vibrio cholerae O1 Infection

14:30—16:30
Workshop 3: Prevention and Therapy

Quandary Peak
* Carola H. Ries, Roche Innovation Center Munich, Germany

* E. John Wherry, University of Pennsylvania, USA

Eduardo Bonavita, Cancer Research UK Manchester Institute, University of Manchester, UK
COX-2 Expression Positively Associates with Tumor-Promoting Inflammatory Factors and Negatively with Anti-Tumor Immune Pathways in Human Cancer

David N. Brindley, University of Alberta, Canada
Blocking the Inflammatory Effects of Lysophosphatidate Signaling as a New Strategy for Decreasing Tumor Growth, Metastasis and Improving Chemotherapy

Feng Zhu, NCI, National Institutes of Health, USA
Fungal Infection and Immune Dysfunction Contribute to Esophageal Carcinogenesis

Kayla Knilans, NIAID, National Institutes of Health, USA
Type 2 Signaling Improves Survival and Reduces Tumor Growth in a Mouse Model of Colitis-Associated Cancer

Jeff Kwak, University of Colorado Denver, USA
Complement Activation Mediates Lung Cancer Progression and Metastasis through Alterations in CD4 T Lymphocytes

Max Wellenstein, Netherlands Cancer Institute, Netherlands
Loss of p53 Drives Systemic Neutrophilic Inflammation in Breast Cancer

16:30—17:00
Coffee Available

Longs Peak Foyer
17:00—19:00
Systems Microbiology
Meeting has ended...abstracts no longer viewable online.

Grays/Longs Peak
* Karen Guillemin, University of Oregon, USA

Timothy K. Lu, Massachusetts Institute of Technology, USA
Engineering the Microbiome

James Amos-Landgraf, University of Missouri, USA
Suppression of Tumor Growth using Biofilm Producing Sulfate-reducing Bacteria in a Rat Model of Colon Cancer

Sean F. Brady, Rockefeller University, USA
Microbial Biosynthetic Diversity

Alexandra Zhernakova, University Medical Center Groningen, Netherlands
Short Talk: Interaction of Genetics and Food Intake Influences Gut Microbiota Composition

17:00—18:45
Prevention and Therapy
Meeting has ended...abstracts no longer viewable online.

Quandary Peak
* Fiona M. Powrie, University of Oxford, UK

Carola H. Ries, Roche Innovation Center Munich, Germany
Combining Macrophage Targeting with Cancer Immunotherapies

Jane L. Grogan, Genentech, Inc., USA
The Inhibitory Immunoreceptor TIGIT Limits Anti-Tumor Immunity

Jen Morton, Cancer Research UK Beatson Institute, Scotland
Short Talk: Myeloid Cells as a Therapeutic Target in Pancreatic Cancer

Kristen M. Larsen, University of South Carolina, USA
Short Talk: The Role of Interleukin 33/ST2 Axis in Liver Metastasis of Colorectal Cancer

19:00—19:15
Meeting Wrap-Up: Outcomes and Future Directions
Meeting has ended...abstracts no longer viewable online.

Grays/Longs Peak
* William Michael Dunne, bioMérieux, Inc., USA

18:45—19:00
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Meeting has ended...abstracts no longer viewable online.

Quandary Peak
19:15—20:15
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Colorado Rockies Ballroom
20:15—23:00
Entertainment
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.

Colorado Rockies Ballroom

FRIDAY, FEBRUARY 10

 
Departure


*Session Chair †Invited, not yet responded.



Keystone Symposia thanks our Sponsors for generously supporting this meeting:

Bill & Melinda Gates Foundation Intercept Pharmaceuticals, Inc.
Merck & Co., Inc. Novartis Institutes for BioMedical Research

We gratefully acknowledge support for this conference from:


Directors' Fund


These generous unrestricted gifts allow our Directors to schedule meetings in a wide variety of important areas, many of which are in the early stages of research.

Click here to view all of the donors who support the Directors' Fund.



We gratefully acknowledge additional support for this conference from:

Anaerobe Systems Diversigen
eLife Research Diets, Inc.
Seres Therapeutics
 

We gratefully acknowledge the generous grant for this conference provided by:


National Institutes of Health

Grant No. 1R13AI129385-01

The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.


We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:



bioMérieux, Inc.


We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:


Click here to view more of these organizations


Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:


Click here to view more of these organizations


If your organization is interested in joining these entities in support of Keystone Symposia, please contact: Sarah Lavicka, Assistant Director of Development, Email: sarahl@keystonesymposia.org,
Phone:+1 970-262-2690

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:
Yvonne Psaila, Director, Marketing and Communications, Email: yvonnep@keystonesymposia.org,
Phone:+1 970-262-2676